Chiara Paoli

Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis

Paola Guglielmelli, Annalisa Pacilli, Giada Rotunno et al. · Blood · 2017 · 180 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +8

The value of the seagrass Posidonia oceanica: A natural capital assessment

Paolo Vassallo, Chiara Paoli, Alessio Rovere et al. · Marine Pollution Bulletin · 2013 · 167 citations

Life Sciences, Ecology, Marine Sciences +14

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

Alberto Álvarez‐Larrán, Arturo Pereira, Paola Guglielmelli et al. · Haematologica · 2016 · 147 citations · Full text

Medicine, Hematology, Pharmacology +17

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study

Paola Guglielmelli, Flavia Biamonte, Giada Rotunno et al. · Blood · 2014 · 129 citations · Full text

Medicine, Hematology, Oncology +15

Understanding relationships between conflicting human uses and coastal ecosystems status: A geospatial modeling approach

Valériano Parravicini, Alessio Rovere, Paolo Vassallo et al. · Ecological Indicators · 2011 · 115 citations

Planning, Environmental Management, Environmental Sciences +16